About Prescription Drug Pricing
Prescription drugs should be affordable — but patients increasingly face challenges getting medication at fair prices. California’s hospitals are committed to ensuring the availability of lifesaving and life-changing medication. More than 180 California hospitals participate in the federal 340B Drug Pricing Program, which provides discount drugs to low-income patients, while many others participate in group purchasing organizations to lower costs. Solutions to rising drug prices must address drivers of cost, like supply shortages and lack of competition, and increase transparency for drug manufacturers.
The Centers for Medicare & Medicaid Services (CMS) announced that Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose from Oct. 1-Dec. 31, 2023.
The Centers for Medicare & Medicaid Services (CMS) announced the first 10 drugs covered under Medicare Part D selected for the Medicare Drug Price Negotiation Program.